{"id":2916,"date":"2016-11-18T01:45:27","date_gmt":"2016-11-18T01:45:27","guid":{"rendered":"http:\/\/www.medicalmarijuanainc.com\/?p=18397"},"modified":"2016-11-18T01:45:27","modified_gmt":"2016-11-18T01:45:27","slug":"report-stonebridge-partners-reveals-growing-market-value-medical-marijuana-inc","status":"publish","type":"post","link":"https:\/\/medicalmarijuanainc.com\/2016\/11\/18\/report-stonebridge-partners-reveals-growing-market-value-medical-marijuana-inc\/","title":{"rendered":"Report by StoneBridge Partners Reveals the Growing Market Value of Medical Marijuana, Inc."},"content":{"rendered":"
In a 24 page report compiled by StoneBridge Partners and published November 15, 2016, the investment firm explored the strength of Medical Marijuana, Inc.\u2019s market position, product pipeline, and portfolio of companies, praising the company\u2019s potential. <\/span><\/p>\n StoneBridge Partners opens the report saying that Medical Marijuana, Inc. is \u201cwell positioned to capitalize on the rapidly developing cannabis industry through its subsidiaries, investments, brands, and partners.\u201d<\/span><\/p>\n The report is overwhelmingly favorable for Medical Marijuana, Inc., closely examining its portfolio of brands, evaluating the global reach of its market presence, and praising its established CBD pipeline. <\/span><\/p>\n This competitive market position is thanks to Medical Marijuana, Inc. investments like AXIM\u00ae Biotechnologies, which is currently developing cannabinoid-based pharmaceutical products for the treatment of conditions like multiple sclerosis, KannaLife\u2122 Sciences, which is licensed by the National Institutes of Health to create cannabinoid-based neuroprotective drugs for chronic traumatic encephalopathy (CTE), hepatic encephalopathy (HE), and other neurological indications, and HempMeds\u00ae, Medical Marijuana, Inc.\u2019s vast distribution wing, created to sell the complete line of Medical Marijuana, Inc. products. <\/span><\/p>\n The report by StoneBridge Partners recognizes the significant growth potential of the cannabis industry and examines Medical Marijuana, Inc.\u2019s competitive placement within the growing market. <\/span><\/p>\n Read the full report <\/span>here<\/span><\/a>, or follow our <\/span>news feed<\/span><\/a> to keep current with information about Medical Marijuana, Inc. and our portfolio of companies. <\/span> \t<\/p>\n","protected":false},"excerpt":{"rendered":" A recent evaluation of Medical Marijuana, Inc. by the StoneBridge Partners private investment firm exposes the company\u2019s significant market potential. In a 24 page report compiled by StoneBridge Partners and published November 15, 2016, the investment firm explored the strength of Medical Marijuana, Inc.\u2019s market position, product pipeline, and portfolio of companies, praising the company\u2019s […]<\/p>\n","protected":false},"author":1,"featured_media":2885,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[3],"tags":[],"class_list":["post-2916","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company-news"],"yoast_head":"\n